Thromboplastin as a Reagent

Summary

Tissue thromboplastin is the key reagent in the one-stage prothrombin time test. To obtain reliable results, a potent thromboplastin with constant activity and stability is required. This need is met by acetone-dehydrated rabbit brain. This reagent, when protected against oxidation by sealing in an evacuated tube, retains its full activity indefinitely. The basic prothrombin time serves as a screening test for depletion of prothrombin, factors V, VII and X. Thromboplastin is slowly inactivated by oxidation and also by bacterial action. Phenol prevents the latter reaction and therefore a phenolized extract of either human brain or acetone-dehydrated rabbit brain serves as a satisfactory reagent for the prothrombin time when employed to control oral anticoagulant therapy.

The constant 12 sec prothrombin time of fresh normal human plasma is fixed by the concentration of active prothrombin. By modifying the basic prothrombin time by adding excess of factors V, VII or X, the test is made a specific quantitative measure of each of these factors.

• References

• 1 Davie E. W, Hougie C, Lundblad R. L. Mechanisms of blood coagulation, Recent Advances in Blood Coagulation. J. & A. Churchill Ltd.; London: 1969: 13-28.
• 2 Gollub S, Feldman D, Schechter D. C, Kaplan F. E, Meranze D. R. Thromboplastinase, a new enzyme which destroys thromboplastin. Proc. Soc. exp. Biol. (N.Y.) 83: 858 1953;
• 3 Izarn P, Hussey C. V, Quick A. J. Comparative thromboplastin activity of acetone-dehydrated rabbit and human brain. Proc. Soc. exp. Biol. (N.Y.) 91: 193 1956;
• 4 Jaques L. B, Dunlop A. P. The effect of calcium concentration on prothrombin of dogs treated with Dicumarol. Amer. J. Physiol 143: 355 1945;
• 5 Mertz E. T, Seegers W. H, Smith H. P. Prothrombin, thromboplastin and thrombin; Quantitative interrelationship. Proc. Soc. exp. Biol. (N.Y.) 42: 604 1938;
• 6 Nour-Eldin F. Preparation of a standard brain thromboplastin, New 1st. Contr. clin. Sci 9: 120 1967;
• 7 Prandoni A, Wright I. The anti-coagulants: Heparin and the dicoumarin-3, 3’ methylene-bis-(4-hydroxycoumarm). Bull. N.Y. Acad. Med 18: 433 1942;
• 8 Quick A. J. On various properties of thromboplastin (aqueous tissue extracts). Amer. J. Physiol 114: 282 1936; Ibid, On the action of heparin and its relation to thromboplastin. Amer. J. Physiol. 115: 317 (1936).
• 9 Quick A. J. The nature of the bleeding in jaundice. JAMA 110: 1658 1938;
• 10 Quick A. J. The Hemorrhagic Diseases and the Physiology of Hemostasis. C. C. Thomas; Springfield: 1942
• 11 Quick A. J. On the quantitative relationship between calcium and prothrombin. Amer. J. Physiol 148: 211 1947;
• 12 Quick A. J. One-stage prothrombin time in the control of anticoagulant therapy. Anticoagulant Therapy in Ischemic Heart Disease. Ed. Sterling Nichol E. Grune & Stratton; New York: 1965: 381-388.
• 13 Quick A. J. Genetic aspects of hemostasis. Thrombos. Diathes. haemorrh. (Stuttg.) 20: 209 1968;
• 14 Quick A. J. Prothrombin estimations. Canad. M.A.J 100: 132 1969;
• 15 Quick A. J, Stanley-Brown M, Bancroft F. W. A study of the coagulation defect in hemophilia and in jaundice. Amer. J. med. Sci 190: 501 1935;
• 16 Sise H. S, Bavelle S. M, Adamis D, Becker R. Relation of hemorrhage and thrombosis to prothrombin during treatment with coumarin-type anticoagulants. New Engl. J. Med 259: 266 1958;
• 17 Toohey M. Prothrombin: Its estimation, clinical significance, and the treatment of hypo-prothrombinaemia. Irish J. med. Sci. Sixth Series 189: 509 1941;
• 18 Toohey M. Prothrombin estimation and dicoumarol. Brit. med. J 1: 518 1950;
• 19 Wilson S. J. Difference during Dicumarol therapy in the Quick and Russell viper venom methods for prothrombin determination. Proc. Soc. exp. Biol. (N.Y.) 66: 126 1947;